LPTX - ערך חשבונאי למניה Leap Tx

Leap Therapeutics, Inc. (LPTX) maintains high authority within the scientific community, confirming its status as a promising developer of immuno-oncology solutions. This book value per share chart demonstrates steady dynamics, where 0.14 represents the current level of the metric. Financial stability is bolstered by partnerships with industry behemoths to develop DKN-01 and robust patent protection for antibodies, ensuring the long-term value of the company's assets.

Full capacity utilization of Leap Therapeutics, Inc. (LPTX) biopharmaceutical antibody production facilities directly impacts the absolute book value per share, reflecting the efficiency of capital management. This indicator is calculated as the ratio of net assets to the number of shares outstanding, allowing investors to assess the real value of their ownership stake and promptly identify capital dilution or asset write-downs.